• Wed news: Lilly’s 4.5B medicine foundry project. 5 FDA decisions to watch in Q4. Hurricane Helene and the health supply chain. Lundbeck taps Charles River for AI-enabled neuro drug discovery. Amgen tax evasion lawsuit. See more on our front page

Team V Exodus

anonymous

Guest
Put a fork in it, this franchise is on the other side of the bell curve with no future indications. BL departure was the beginning of the end IMHO. Bonus has been paid out and I sense many are looking to greener pastures.
 

<



















The last NSM has me looking elsewhere. No positive take aways. MB has us chanting BS like cheerleaders, did he really think that was motivational? New regional jumping around on stage, picking people up like a little girl when he won Summit. Has he ever won an award before? He was here 6m in 2023, how was he eligible? DF got screwed again! She's not appreciated and many don't think she'll be here much longer. Unless GNE agreement is broken, this sales force is toast.
 




Poor leadership and misguided priorities have deeply hurt this franchise. Now they're doubling down with neurodiversity woke nonsense? It's time to clean house and put leaders in place who can bring us back to some resemblance of what a top oncology unit should look like.
 




Woke EEDI promoted transgender day of visibility on Easter Sunday! If this was a Muslim holiday it wouldn't have happened, scared of insulting a religion that routinely eradicates people of this persuasion.
 
























Similar threads

Replies
3
Views
1K
AbbVie
anonymous
Replies
59
Views
20K
AbbVie
anonymous
Replies
7
Views
2K
AbbVie
anonymous
Replies
2
Views
2K
AbbVie
Dixie Normous